Novel Adjuvants for Peptide-Based Melanoma Vaccines
Clinical trial NCT00028431 · COMPLETED
Trial details
- NCT number
- NCT00028431
- Sponsor
- University of Southern California
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2001-08-01
- Primary completion
- 2003-01-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.